Zurich, Zurich, Switzerland
Experienced Healthcare Professional with demonstrated track record in Pharmaceuticals, Medical Devices and Surgical Ophthalmology; expertise in Advisory Functions, General Management, Business Development, Acquisitions and Integration; strong focus on Commercialisation, In-licensing, and Start-ups; over 20 years in Asia, since 2019 back in Europe, based in Zurich. Dual Master Degree from University of St.Gallen (HSG) and University of Zurich..
machineMD is a Swiss medical device start-up founded in 2019 that develops standardised ophthalmological tests for the early detection of neurological conditions such as stroke, multiple sclerosis and brain tumours. It combines Virtual Reality and Artificial Intelligence to assist neurologists and ophthalmologists in reliably diagnosing patients.
Von Hoff is a leading commercialisation service provider to ophthalmologists, optometrists and opticians in Switzerland; focus on diagnostic equipment and devices; expanding into surgical ophthalmology and becoming the go-to partner for eye surgeons in the Swiss market.
Nucleoptis International owns and acquires stakes in companies primarily within the med tech sector with special focus on eye care.
Member of the Executive Board of Vision Ophthalmology Group (now: AddVision), driving acquisitions and integration of new businesses within surgical ophthalmology. In charge of identifying leads, leading negotiations, and solve operational and contractual matters vis-a-vis our business partners and suppliers. Group management responsibility including Profit & Loss.
Leading the commercial business development initiatives for the Group, identifying and evaluating leads, and closing deals with MNCs mainly for pharmaceutical products (prescription and OTC) as well as medical devices. Negotiating long-term contracts for established brands as well as in-licensing of novel, innovative products from US, Europe and Japan.